In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) closed at $6.62 down -4.61% from its previous closing price of $6.94. In other words, the price has decreased by -$4.61 from its previous closing price. On the day, 1.18 million shares were traded. PHAT stock price reached its highest trading level at $6.9014 during the session, while it also had its lowest trading level at $6.355.
Ratios:
For a deeper understanding of Phathom Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.68 and its Current Ratio is at 5.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 03, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $23 to $26.
On August 09, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $28.H.C. Wainwright initiated its Buy rating on August 09, 2023, with a $28 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 19 ’24 when Nabulsi Azmi sold 1,118 shares for $8.00 per share. The transaction valued at 8,944 led to the insider holds 239,303 shares of the business.
Henderson Molly sold 1,291 shares of PHAT for $10,328 on Dec 19 ’24. The CFO and CBO now owns 98,156 shares after completing the transaction at $8.00 per share. On Dec 13 ’24, another insider, KARBE FRANK, who serves as the Director of the company, bought 12,500 shares for $7.93 each. As a result, the insider paid 99,084 and bolstered with 57,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 474538816 and an Enterprise Value of 636972096. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.23. Its current Enterprise Value per Revenue stands at 24.247 whereas that against EBITDA is -2.218.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.58, which has changed by -0.075898826 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $6.07. The 50-Day Moving Average of the stock is -33.75%, while the 200-Day Moving Average is calculated to be -45.02%.
Shares Statistics:
For the past three months, PHAT has traded an average of 1.30M shares per day and 891560 over the past ten days. A total of 68.32M shares are outstanding, with a floating share count of 34.87M. Insiders hold about 49.01% of the company’s shares, while institutions hold 68.83% stake in the company. Shares short for PHAT as of 1734048000 were 14131833 with a Short Ratio of 11.52, compared to 1731628800 on 14663729. Therefore, it implies a Short% of Shares Outstanding of 14131833 and a Short% of Float of 29.17.
